![](/fileadmin/_processed_/csm_Elsie_e778d3c6d7.png)
GSK closes US$50m acquisition with Elsie Biotechnologies Inc
GlaxoSmithKline (GSK) plc has acquired Elsie Biotechnologies Inc, a San Diego-based biotechcompany dedicated to unlocking the potential of...
![](/fileadmin/_processed_/csm_Product_Award_winners_88844c23d2.png)
SLAS Europe 2024 honours products with most impact
Two companies were selected by the SLAS Europe 2024 jury from 13 applicants and six finalists as winners of this year's Product Award in Barcelona:...
![](/fileadmin/_processed_/csm_HIV__63e20764dc.jpg)
Naobios and Sumagen partner to develop HIV vaccine
Under the contract, Naobios SAS will provide bioprocess development and GMP production of clinical batches of a virus-based HIV vaccine candidate...
![](/fileadmin/_processed_/csm_RNF31_Pub_domain__c__RCBS_protein_data_base_62ddf70879.jpg)
Flindr Therapeutics BV secures €20m Series A financing
The Series A financing was led by V-Bio Ventures and an international syndicate that includes Johnson & Johnson Innovation – JJDC, Inc., QBIC...
![](/fileadmin/_processed_/csm_Ignate1_SLAS_19d7db8119.png)
Semarion Ltd. wins Ignite SME award at SLAS Europe
Last night, the 19,000-member Society for Laboratory Automation and Screening (SLAS) has been presenting the Ignite Award for the most...
![](/fileadmin/_processed_/csm_Amphistar_c6faa8b918.jpg)
AmphiStar BV secures €6m to expand production
The infusion of €6m in new capital from ECBF, Qbic III and FFTF will empower AmphiStar to kickstart commercial biosurfactant production in...
![](/fileadmin/Content/NewsAndStories/2024/National_Eye_Institute.png)
Seabelife SAS to develop next-gen dry AMD drug
French drug developer SeaBeLife SAS has bagged a €1.5m fund within the i-Nov 2024 innovation competition, which is part of the French government’s...